Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
2.540
+0.090 (3.67%)
Dec 20, 2024, 4:00 PM EST - Market closed
Erasca Employees
Erasca had 126 employees as of December 31, 2023. The number of employees decreased by 3 or -2.33% compared to the previous year.
Employees
126
Change (1Y)
-3
Growth (1Y)
-2.33%
Revenue / Employee
n/a
Profits / Employee
-$1,262,849
Market Cap
718.13M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 126 | -3 | -2.33% |
Dec 31, 2022 | 129 | 6 | 4.88% |
Dec 31, 2021 | 123 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Avanos Medical | 3,771 |
Bioventus | 970 |
Relay Therapeutics | 323 |
Evolus | 273 |
Kura Oncology | 142 |
Keros Therapeutics | 136 |
Immunome | 55 |
Dianthus Therapeutics | 53 |
ERAS News
- 5 weeks ago - Erasca Reports Third Quarter 2024 Business Updates and Financial Results - GlobeNewsWire
- 6 weeks ago - Erasca to Present at Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Erasca Reports Second Quarter 2024 Business Updates and Financial Results - GlobeNewsWire
- 7 months ago - Erasca to Present at Upcoming Investor Conferences in June - GlobeNewsWire
- 7 months ago - Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 7 months ago - Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise - GlobeNewsWire
- 7 months ago - Erasca Announces Pricing of Underwritten Offering of Common Stock - GlobeNewsWire
- 8 months ago - Erasca Reports First Quarter 2024 Business Updates and Financial Results - GlobeNewsWire